Palladone (Hydromorphone Hydrochloride)

Hydromorphone hydrochloride, the active ingredient in Palladone, is an opioid analgesic presented as a strength/form for oral use. It is prescribed for management of moderate to severe pain in adult patients when alternative treatments are inadequate. GNH USA supplies Palladone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Palladone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Hydromorphone hydrochloride is an opioid analgesic that acts on the central nervous system to relieve pain.

- Acute postoperative pain: provides strong analgesia during the immediate recovery period. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: offers relief when other opioids or non‑opioid analgesics are insufficient.

Hydromorphone hydrochloride may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate queasiness. - Drowsiness: increased sleepiness or sedation. - Dry mouth: decreased salivary flow. - Sweating: excessive perspiration. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, or anaphylaxis. - Dependence or addiction: potential for misuse with prolonged use. - Seizures: rare neurologic events. - Urinary retention: difficulty emptying the bladder.

When prescribing hydromorphone hydrochloride, clinicians should consider several safety measures.

- Assess pain severity: confirm that opioid therapy is appropriate. - Evaluate patient history: screen for respiratory disorders, substance misuse, or head injury. - Monitor for sedation: watch for excessive drowsiness or impaired cognition. - Adjust dose cautiously: titrate based on response and tolerability. - Educate on constipation: advise prophylactic laxatives and fluid intake. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Hydromorphone hydrochloride can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression. - CNS depressants: additive sedation and lowered consciousness. - MAO inhibitors: may precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - Anticholinergics: may worsen constipation. - CYP3A4 inhibitors (e.g., ketoconazole): increase hydromorphone plasma levels. - CYP3A4 inducers (e.g., rifampicin): reduce analgesic effect.